ANGEN.E — Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret A Cashflow Statement
0.000.00%
- TRY2.27bn
- TRY2.47bn
- TRY739.63m
Annual cashflow statement for Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret A, fiscal year end - December 31st, TRY millions except per share, conversion factor applied.
C2021 December 31st | R2022 December 31st | R2023 December 31st | R2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 443 | -10.1 | -197 | -286 | -313 |
| Depreciation | |||||
| Non-Cash Items | 1.24 | 0.509 | -17.1 | 240 | 265 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -47.3 | -186 | 189 | -86.6 | 87 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 407 | -135 | 61.1 | 9.82 | 187 |
| Capital Expenditures | -77.4 | -141 | -167 | -323 | -436 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 10 | -70.7 | 16.1 | 25.7 | 9.16 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -67.4 | -212 | -151 | -297 | -427 |
| Financing Cash Flow Items | -2.07 | 27.8 | 39.9 | 0.12 | -15 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -12.8 | -545 | -236 | -14.8 | 74.7 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 327 | -893 | -326 | -302 | -166 |